Concepedia

Author

Thomas Klingebiel

Goethe University Frankfurt

Also Known As

Stefan S. Bielack, T H. Klingebiel, T Klingebiel, T. H. Klingebiel, THOMAS KLINGEBIEL, Thomas Klingebiel

126

Publications

5.2K

Citations

37

H-Index

74

Concepts

All Affiliations

Goethe University FrankfurtUniversity Hospital FrankfurtOlgahospitalUniversity Children's Hospital TübingenKlinikum Stuttgart
TK

About

Thomas Klingebiel is an author at Goethe University Frankfurt specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

20

1.1K

2

Health Sciences

6

6

476

3

Blood Transplantation

2

2

95

4

Cell Biology

2

2

67

5

Biomedical Engineering

1

1

42

Thomas Klingebiel

×

62

Publications

4.8K

Citations

36

H-Index

YearCitations

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

Anja Möricke, Alfred Reiter, Martin Zimmermann,

Blood

2008

601

Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

Alfred Reiter, Martin Schrappe, Markus Tiemann,

PubMed

1999

404

Breast carcinoma during pregnancy

Sibylle Loibl, Gϋnter von Minckwitz, Karin Gwyn,

Cancer

2005

297

Results of Treatment for Soft Tissue Sarcoma in Childhood and Adolescence: A Final Report of the German Cooperative Soft Tissue Sarcoma Study CWS-86

Ewa Kościelniak, D. Harms, Günter Henze,

Journal of Clinical Oncology

1999

269

Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia

Andrea Meinhardt, Birgit Burkhardt, Martin Zimmermann,

Journal of Clinical Oncology

2010

186

Cooperative Trial CWS-91 for Localized Soft Tissue Sarcoma in Children, Adolescents, and Young Adults

Tobias M. Dantonello, Christoph Int‐Veen, D. Harms,

Journal of Clinical Oncology

2009

177

Isolation of Highly Purified Autologous and Allogeneic Peripheral CD34+ Cells Using the CliniMACS Device

Michael Schumm, Peter Lang, Gwendolyn Taylor,

Journal of Hematotherapy

1999

150

A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a

Rupert Handgretinger, Peter Baader, R. Dopfer,

Cancer Immunology Immunotherapy

1992

149

Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults

Tobias M. Dantonello, Christoph Int‐Veen, Ivo Leuschner,

Cancer

2008

148

Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy

Thorsten Simon, Barbara Hero, Andreas Faldum,

BMC Cancer

2011

129

Page 1